Jp
/
En
Mission
Technology
About us
Management
Contact
News
2023.01.17
Mr. Hayakawa was appointed as our board director
2022.12.12
Raised 1.6 billion yen through third-party allotment to prepare for clinical trials of ASCL-PLC
2022.11.10
Concluded a basic agreement with H.U. Cells, Inc. regarding contracted business for PRP therapy
2022.06.20
Notice of Management Change
2022.03.08
Raised JPY 152 million through third-party allotment for the early commercialization of ASCL-PLC, a...
2021.08.10
The disclosed information of the clinical study has been updated
2020.10.16
AdipoSeeds raised 4 million JPY
2020.06.14
AdipoSeeds received an acceptance about the compliance of the clinical study to the guideline for t...
2019.04.09
The paper of ASCL-PLC was adopted as Plenary Paper of Blood
2018.11.04
The patent of manufacturing platelets from adipose tissue-derived mesenchymal stem cell was registe...
2018.09.10
AdipoSeeds became an affiliated institution for the research program funded by AMED
HOME
HOME
NEWS